Trials / Withdrawn
WithdrawnNCT03571919
Lidocaine Infusions for Rib Fractures
Efficacy of Intravenous Lidocaine Infusion for Traumatic Rib Fracture Pain Control
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with traumatic rib fractures not receiving regional anesthesia through a epidural or nerve block catheter will be recruited for the study. Once enrolled, they will be randomized to receive either intravenous lidocaine or intravenous saline for control of pain related to their rib fractures. In addition, they will receive other pain medications, such as acetaminophen, gabapentin, and opioid pain medications. Our primary outcome is a decrease in their opioid medication requirements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine infusion | Intravenous bolus of lidocaine (1.25 mg/kg) and then infusion at 1 mg/kg/hr |
| DRUG | Saline infusion | Intravenous bolus of saline and then infusion |
Timeline
- Start date
- 2018-06-15
- Primary completion
- 2019-06-01
- Completion
- 2019-07-01
- First posted
- 2018-06-28
- Last updated
- 2021-06-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03571919. Inclusion in this directory is not an endorsement.